261 related articles for article (PubMed ID: 23681193)
1. Protein kinases of Toxoplasma gondii: functions and drug targets.
Wei F; Wang W; Liu Q
Parasitol Res; 2013 Jun; 112(6):2121-9. PubMed ID: 23681193
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
mBio; 2016 May; 7(3):. PubMed ID: 27247232
[TBL] [Abstract][Full Text] [Related]
4. Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
Han Y; Adeyemi OS; Kabir MHB; Kato K
Parasitol Res; 2020 May; 119(5):1675-1681. PubMed ID: 32236711
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.
Wang JL; Huang SY; Li TT; Chen K; Ning HR; Zhu XQ
Parasitol Res; 2016 Feb; 115(2):697-702. PubMed ID: 26499803
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii.
Brumlik MJ; Wei S; Finstad K; Nesbit J; Hyman LE; Lacey M; Burow ME; Curiel TJ
Int J Parasitol; 2004 Oct; 34(11):1245-54. PubMed ID: 15491587
[TBL] [Abstract][Full Text] [Related]
8. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
Moine E; Dimier-Poisson I; Enguehard-Gueiffier C; Logé C; Pénichon M; Moiré N; Delehouzé C; Foll-Josselin B; Ruchaud S; Bach S; Gueiffier A; Debierre-Grockiego F; Denevault-Sabourin C
Eur J Med Chem; 2015 Nov; 105():80-105. PubMed ID: 26479029
[TBL] [Abstract][Full Text] [Related]
9. A novel Toxoplasma gondii calcium-dependent protein kinase.
Tzen M; Benarous R; Dupouy-Camet J; Roisin MP
Parasite; 2007 Jun; 14(2):141-7. PubMed ID: 17645186
[TBL] [Abstract][Full Text] [Related]
10. The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.
Fox BA; Rommereim LM; Guevara RB; Falla A; Hortua Triana MA; Sun Y; Bzik DJ
mBio; 2016 May; 7(3):. PubMed ID: 27165797
[TBL] [Abstract][Full Text] [Related]
11. Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.
Moine E; Moiré N; Dimier-Poisson I; Brunet K; Couet W; Colas C; Van Langendonck N; Enguehard-Gueiffier C; Gueiffier A; Héraut B; Denevault-Sabourin C; Debierre-Grockiego F
Int J Parasitol; 2018 Jun; 48(7):561-568. PubMed ID: 29524527
[TBL] [Abstract][Full Text] [Related]
12. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.
Donald RG; Zhong T; Wiersma H; Nare B; Yao D; Lee A; Allocco J; Liberator PA
Mol Biochem Parasitol; 2006 Sep; 149(1):86-98. PubMed ID: 16765465
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.
Eaton MS; Weiss LM; Kim K
Int J Parasitol; 2006 Jan; 36(1):107-14. PubMed ID: 16216248
[TBL] [Abstract][Full Text] [Related]
14. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
[TBL] [Abstract][Full Text] [Related]
16. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
[No Abstract] [Full Text] [Related]
17. Gefitinib inhibits the growth of Toxoplasma gondii in HeLa cells.
Yang Z; Ahn HJ; Nam HW
Korean J Parasitol; 2014 Aug; 52(4):439-41. PubMed ID: 25246725
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
Rutaganira FU; Barks J; Dhason MS; Wang Q; Lopez MS; Long S; Radke JB; Jones NG; Maddirala AR; Janetka JW; El Bakkouri M; Hui R; Shokat KM; Sibley LD
J Med Chem; 2017 Dec; 60(24):9976-9989. PubMed ID: 28933846
[TBL] [Abstract][Full Text] [Related]
19. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
el Kouni MH
Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
[TBL] [Abstract][Full Text] [Related]
20. The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug design.
Cardew EM; Verlinde CLMJ; Pohl E
Parasitology; 2018 Feb; 145(2):210-218. PubMed ID: 29191253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
